Chulani Karunatilake
Hoofd Techniek/Wetenschap/O&O bij WEREWOLF THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Chulani Karunatilake is currently the Chief Technology Officer at Werewolf Therapeutics, Inc. He previously worked as Vice President at Nektar Therapeutics and Senior Vice President-Technical Operations at Maverick Therapeutics, Inc. He holds a doctorate degree from the University of Illinois and an undergraduate degree from the University of Colombo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-01-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Chulani Karunatilake
| Bedrijven | Functie | Begin |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-06-2021 |
Eerdere bekende functies van Chulani Karunatilake
| Bedrijven | Functie | Einde |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Corporate Officer/Principal | - |
Opleiding van Chulani Karunatilake
| University of Illinois | Doctorate Degree |
| University of Colombo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |